Immunization: Importance in Disease Prevention and Public Health

Immunization is the process through which an individual is made immune or resistant to an infectious disease, typically through the administration of a vaccine. Vaccination, often used interchangeably with immunization, works by stimulating the body’s immune system to recognize and respond effectively to disease-causing organisms such as bacteria, viruses, or toxins. Vaccines introduce a harmless component or weakened form of a pathogen, or in some cases genetic material that encodes pathogen antigens, prompting the immune system to produce specific antibodies and memory cells without causing the actual disease.

Once this immune memory is established, the body is able to mount a rapid and targeted response upon future exposure to the same pathogen. This secondary immune response is usually strong enough to prevent infection entirely or significantly reduce the severity and duration of illness. As a result, immunization plays a critical role in reducing morbidity and mortality associated with many infectious diseases, including measles, polio, influenza, hepatitis, and more recently COVID-19.

Beyond individual protection, immunization has a major public health impact through the concept of herd immunity. When a sufficiently large proportion of a population is immunized (a process known as herd immunity), the spread of infectious agents is significantly reduced, thereby protecting individuals who are not vaccinated, such as infants, immunocompromised patients, or those who cannot receive vaccines for medical reasons. This community-level protection helps interrupt transmission chains and can lead to the elimination or eradication of certain diseases.

Immunization programs are therefore among the most cost-effective and successful public health interventions. They reduce healthcare costs, prevent outbreaks, and improve overall life expectancy and quality of life. However, the effectiveness of immunization depends on high coverage rates, public trust, and equitable access to vaccines across all populations.

Immunization defined in a layman’s understanding  

Immunization, in simple terms, is a way of protecting the body from diseases without having to experience the illness itself. Normally, when a person gets sick, the body naturally produces special proteins called antibodies to fight off the infection. After recovery, these antibodies, along with immune memory cells, remain in the body and help protect against future infections from the same disease. This lasting protection is known as immunity.

However, it is not necessary to become ill in order to develop immunity. Immunization makes it possible to build this protection safely through vaccines. Vaccines train the immune system by introducing a weakened, inactive, or harmless part of a disease-causing organism. This allows the body to recognize the disease in advance and prepare a defense without causing illness. As a result, if the person is later exposed to the actual disease, their immune system responds quickly and effectively, preventing infection or reducing its severity.

The public health and economic impact of immunization

Immunization is widely regarded as one of the most effective and cost-efficient interventions in modern public health practice. Its preventive nature distinguishes it from curative healthcare approaches, as it reduces the incidence of disease before infection occurs. By preventing illness rather than treating it after onset, immunization significantly lowers the financial burden on individuals, healthcare systems, and governments. The costs associated with vaccine delivery are substantially lower than those required for managing outbreaks, hospitalizations, long-term complications, and productivity losses resulting from infectious diseases.

Over the past century, immunization has been instrumental in transforming global health outcomes. It has contributed to the control, elimination, and in some cases complete eradication of several devastating infectious diseases. A notable example is smallpox, which was eradicated globally through a coordinated vaccination campaign led by the World Health Organization. Other diseases such as polio, measles, diphtheria, and tetanus have been dramatically reduced in prevalence due to sustained immunization efforts, although some remain endemic in regions with low vaccine coverage.

The impact of vaccines is especially significant in reducing child mortality. Global health data indicate that immunization prevents an estimated two to three million deaths annually, with the majority of beneficiaries being children under the age of five. This reduction in mortality has also contributed to improved life expectancy and healthier population structures in many low- and middle-income countries.

In addition to preventing deaths, immunization reduces the incidence of severe complications associated with infectious diseases, such as disability, neurological damage, and chronic illness. These benefits extend beyond individual health, improving educational attainment and economic productivity by ensuring healthier childhood development. Immunization remains a cornerstone of preventive medicine, delivering substantial health, social, and economic benefits. Its continued success depends on sustained investment, equitable vaccine distribution, and strong public health infrastructure to maintain high coverage rates globally.

Accessibility, affordability, and public health value of immunization

One of the most significant advantages of immunization lies in its affordability and broad accessibility compared to many other medical interventions. Vaccination programs are strategically designed with clearly defined target populations to maximize health impact. These groups typically include infants, young children, pregnant women, the elderly, and individuals with weakened immune systems who are at higher risk of severe outcomes from infectious diseases. By prioritizing these populations, immunization programs ensure that limited health resources are directed where they are most needed.

A key strength of immunization systems is their integration into routine healthcare delivery. Vaccines are administered through structured immunization schedules, which guide when and how different vaccines should be given across the life course of a person. In addition, outreach campaigns, mobile clinics, school-based programs, and community health initiatives help extend vaccine coverage beyond formal healthcare facilities. These delivery strategies are particularly important in reaching populations living in remote, rural, or underserved urban areas where access to healthcare services may be limited. As a result, immunization plays a central role in reducing health disparities and promoting equity in global health systems.

Another important advantage of vaccination is that it requires minimal behavioral change compared to many other disease prevention strategies. Unlike interventions that depend on sustained individual action such as dietary modification, exercise routines, or long-term medication adherence, vaccination typically involves a limited number of scheduled visits while providing long-lasting or even lifelong immunity. This simplicity increases acceptance and compliance at the population level, making immunization one of the most practical preventive health tools available.

From an economic perspective, immunization is highly cost-effective. By preventing infectious diseases before they occur, vaccination reduces the need for expensive medical treatments, hospital admissions, emergency care, and long-term management of complications or disabilities. It also helps avoid indirect costs such as loss of productivity due to illness or caregiving responsibilities. During outbreaks, vaccination further reduces the economic burden associated with epidemic control measures and strained healthcare systems.

For these reasons, governments, international organizations, and public health agencies continue to prioritize immunization as a core component of primary healthcare. It remains a cornerstone of sustainable health development, contributing not only to individual protection but also to stronger, more resilient health systems worldwide.

Immunity through immunization

Immunization (or vaccination) protects people from disease by introducing a vaccine into the body that triggers an immune response, just as though you had been exposed to a disease naturally. The vaccine contains the same antigens or parts of antigens that cause the disease, but the antigens in vaccines are either killed or greatly weakened. Vaccines work because they trick your body (in this case your immune system) into thinking it is being attacked by the actual disease; and in the process, plenty amount of immunological weapons (e.g., antibodies) will be produced to attack the invading pathogen.

Immunity through immunization happens without the consequence of being ill and without the risk of potential life-threatening complications from the disease. Once a person is immunized, specific immune cells called memory cells prevent re-infection when they encounter that same disease again in the future. However, not all vaccines provide lifelong immunity. Vaccines such as the tetanus vaccine require booster doses every ten years for adults to maintain immunity.

Immunization is not just for children

At any age, vaccination provides the longest-lasting, most effective protection against disease. Vaccine-preventable diseases can be serious, and in some cases can cause life-threatening complications that can lead to hospitalization. This is especially a concern for infants and young children, who are particularly more vulnerable. Having children vaccinated on time is important and helps ensure that they receive the protection they need as early as possible to fight off diseases before they are even exposed to them.

Immunization is important not only in childhood, but in adulthood as well, to help promote healthy aging. This is because childhood immunization does not provide lifelong immunity against some diseases such as tetanus (lockjaw) and diphtheria. Adults require helper, or booster, shots to maintain immunity. Adult vaccinations may also be recommended to protect against disease common in adulthood such as shingles.

Adults who were not adequately immunized as children may be at risk of infection from other vaccine-preventable diseases. They can also infect others. For example, adults who become ill with measles, mumps or pertussis (whooping cough) can infect infants who may not yet be fully immunized.

Since the introduction of vaccines, many serious illnesses have been brought under control.
Immunization can protect people from many infectious diseases including:

• blood infection

• diphtheria

• ear infection

• Haemophilus influenzae type b

• hepatitis A

• hepatitis B

• Human papillomavirus (HPV)

• Influenza

• measles (red measles)

• meningitis

• mumps

• pertussis (whooping cough)

• pneumonia

• polio

• rotavirus

• rubella (German measles)

• tetanus (lockjaw)

• varicella (chickenpox)

Why is immunization important?

Immunization is important because it is one of the best ways that humans can protect themselves and future generations from infectious diseases and their causative agents. People who are vaccinated against a particular infection or disease help to build herd immunity in the general population; and this helps to wipe out disease that could spread now and into the future.

• Immunization helps to stop the spread of infectious diseases in a human population.

• It saves lives and helps protect the future generation from being infected.

• Vaccination helps the human population to develop immunity against infectious diseases and their causative agents.

How do vaccinations work?

All immunizations work in the same way. The vaccination uses your body’s immune system to increase protection to an infection before you come into contact with that infection. In other words, it is like being infected with the disease without suffering the actual symptoms. Usually, some particles from the actual pathogen are used in the production of the vaccine. These particles are usually attenuated or weakened so that they do not cause any illness in the population receiving the vaccination. If you come into contact with an infection after you’ve been vaccinated, your body works to stop you from getting the disease, or you may get just a mild case. Unlike other proposed approaches to immunization (such as homeopathy), vaccinations have been rigorously tested to demonstrate their safety and effectiveness in protecting against infectious disease. 

What about people who cannot be immunized?

Some people in our community cannot be vaccinated. This might be because they are too young or too sick. You can help protect these vulnerable people by keeping your family’s vaccinations up to date. When enough people in the community are vaccinated, the spread of a disease slows down or stops completely. So as long as enough people are vaccinated, the disease will not spread. This is called herd immunity. 

Modern outbreaks of infectious diseases

Many infectious diseases are rare or not around anymore, thanks to vaccination. But there are still some infectious disease outbreaks happening around the world today. Some of the most notable are as follows:

Coronavirus disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19) is an infectious respiratory illness caused by a novel coronavirus known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This virus belongs to a family of coronaviruses that can infect humans and animals, but SARS-CoV-2 is a newly identified strain responsible for the global pandemic that emerged in late 2019. The disease primarily spreads through respiratory droplets when an infected person coughs, sneezes, speaks, or breathes, and it can also spread through contaminated surfaces in certain conditions. COVID-19 has had far-reaching consequences beyond public health, significantly disrupting global economies, healthcare systems, education, and social activities. Many countries experienced severe economic downturns due to lockdown measures, travel restrictions, reduced workforce productivity, and strain on healthcare infrastructure. Even highly developed nations were not spared from its impact.

Clinically, COVID-19 ranges from mild symptoms such as fever, cough, and fatigue to severe illness including pneumonia, acute respiratory distress syndrome, organ failure, and death, particularly among older adults and individuals with underlying health conditions. Since its emergence, the disease has caused millions of deaths worldwide, with the United States and several European countries among the most affected in terms of both infection rates and mortality. At the early stages of the pandemic, there was no specific cure or widely available vaccine, which contributed to its rapid spread and high fatality rates. However, intensive global research efforts led to the development of diagnostic tools, therapeutic approaches, and eventually effective vaccines, marking a major milestone in controlling the disease. Despite these advances, COVID-19 continues to circulate globally, requiring ongoing surveillance and public health interventions.

Vaccine-preventable diseases and the risk of resurgence

Influenza (flu), chickenpox, whooping cough (pertussis), and measles remain important vaccine-preventable diseases that continue to cause periodic outbreaks in Australia and many other parts of the world. Although vaccination programs have significantly reduced their incidence, these infections have not been fully eliminated and can still be introduced through international travel or migration from regions where transmission is ongoing. Measles, in particular, is highly contagious and serves as a key indicator of immunization coverage within populations. When vaccination rates decline, even slightly, the likelihood of outbreaks increases rapidly due to the ease with which the virus spreads among unprotected individuals. Similar concerns apply to whooping cough and influenza, which can circulate seasonally and disproportionately affect infants, the elderly, and individuals with weakened immune systems.

A major concern in public health is the potential resurgence of these diseases if vaccination uptake decreases due to hesitancy or access barriers. Historical patterns have shown that reduced immunization coverage is often followed by increased transmission and outbreaks, reversing years of progress in disease control. This risk is reflected in global surveillance data. For example, in January 2019, 62,225 measles cases were reported worldwide, compared to 23,535 cases during the same period in 2018. This sharp increase highlights how quickly measles can re-emerge when immunity gaps exist within populations. These diseases remain a persistent public health threat, reinforcing the importance of maintaining high vaccination coverage to prevent resurgence and protect vulnerable groups.

Zika virus as a global public health concern

In February 2016, the World Health Organization (WHO) declared the Zika virus outbreak a Public Health Emergency of International Concern due to its rapid spread across Central and South America. The declaration was prompted not only by the increasing number of infections but also by the emerging evidence linking Zika virus infection during pregnancy to serious birth defects, particularly microcephaly and other congenital neurological abnormalities. Following the initial outbreak, evidence of Zika virus transmission continued to be reported across multiple regions, including the Americas, parts of Africa, and other tropical and subtropical areas where Aedes mosquitoes, the primary vectors, are present. By 2018, approximately 86 countries and territories had reported mosquito-borne transmission of Zika virus, highlighting its widespread geographic distribution and the persistent risk of re-emergence.

Despite intensive global efforts to control the spread of the disease through vector control and public health awareness campaigns, no approved vaccine or specific antiviral treatment currently exists for Zika virus infection. Management remains largely supportive, focusing on symptom relief and prevention of complications. However, scientific research into vaccine development is ongoing, alongside studies aimed at improving diagnostic tools and understanding viral transmission dynamics. These efforts are critical for strengthening global preparedness and reducing the future impact of Zika outbreaks on vulnerable populations.

Ebola virus disease and recent outbreak status

Ebola virus disease (EVD) is a severe, often fatal illness caused by the Ebola virus, which belongs to the Filoviridae family. It is transmitted to humans through direct contact with infected wildlife and then spreads through human-to-human transmission via bodily fluids such as blood, vomit, or other secretions. The disease is characterized by sudden onset of fever, severe weakness, muscle pain, and in many cases internal and external bleeding. Because of its high case fatality rate, Ebola is considered one of the most dangerous viral infections affecting humans. The most recent major outbreak began in August 2018 in the Democratic Republic of Congo (DRC). This outbreak became the second-largest Ebola epidemic in history, after the West African outbreak of 2014-2016. 

Although the situation was extremely challenging due to ongoing regional conflict, population movement, and difficulties in implementing public health measures, coordinated response efforts by national authorities and international partners eventually helped bring the outbreak under control. Despite progress in outbreak management, Ebola virus disease remains a serious public health concern. Unlike many other infectious diseases, there is still no universally available cure, although supportive care and experimental treatments can improve survival rates. However, significant progress has been made in vaccine development. An effective vaccine has since been approved and used in outbreak settings to contain transmission, while additional vaccine research and therapeutic trials continue to improve preparedness for future outbreaks.

Just recently in 2026, the World Health Organization (WHO) has reported an outbreak of Ebola virus disease caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda, prompting consideration of a public health emergency of international concern. As of 16 May 2026, reported figures include eight laboratory-confirmed cases, 246 suspected cases, and approximately 80 suspected deaths in Ituri Province, DRC. These cases are distributed across multiple affected health zones, including Bunia, Rwampara, and Mongbwalu. In parallel, two laboratory-confirmed cases, including one death, were identified in Kampala, Uganda, within 24 hours of each other on 15-16 May 2026. Both cases had recent travel history from the DRC but no clear epidemiological link to each other, indicating possible multiple transmission pathways.

Additional reports describe unusual clusters of community deaths with symptoms consistent with viral haemorrhagic fever across several health zones in Ituri, alongside suspected cases in both Ituri and North Kivu. Of particular concern are at least four deaths among healthcare workers, suggesting potential nosocomial transmission and gaps in infection prevention and control practices. Preliminary data indicate significant uncertainty regarding the true scale and geographic spread of the outbreak. High positivity rates among tested samples, increasing suspected case reports, and cross-border detection in Uganda collectively suggest that the outbreak may be substantially larger than currently confirmed.

Contributing factors such as insecurity, population displacement, high mobility, and reliance on informal healthcare systems further increase transmission risk, similar to prior Ebola outbreaks in eastern DRC. Unlike Ebola virus disease caused by Zaire ebolavirus, there are currently no approved vaccines or specific therapeutics for Bundibugyo virus infection, increasing the potential severity of this event. International spread has already occurred, and neighbouring States are considered at high risk due to porous borders and intense movement of people and goods. 

HIV/AIDS: global emergence and ongoing public health challenge

HIV/AIDS was first recognized in 1981, when unusual clusters of opportunistic infections and rare cancers were identified among gay men in the United States. These early cases marked the beginning of what would become one of the most significant global public health crises of the modern era. By 1985, reported cases of HIV infection had spread to every region of the world, highlighting the rapid and widespread transmission of the virus across populations and geographic boundaries. Human Immunodeficiency Virus (HIV) attacks the body’s immune system, specifically targeting CD4 T cells, which are essential for immune defense. If left untreated, HIV can progress to acquired immunodeficiency syndrome (AIDS), a condition characterized by severe immune suppression and increased vulnerability to opportunistic infections and certain cancers.

By 2017, an estimated 36.9 million people globally were living with HIV/AIDS, reflecting both the scale of the epidemic and improvements in diagnosis and reporting. Although there is currently no definitive cure or preventive vaccine for HIV, significant progress has been made in treatment. Antiretroviral therapy (ART) effectively suppresses viral replication, allowing individuals living with HIV to maintain near-normal life expectancy and a good quality of life when treatment is consistently followed. Despite these advances, HIV/AIDS remains a major global health concern, particularly in regions with limited access to healthcare, prevention services, and sustained treatment coverage.

References

www.betterhealth.vic.gov.au/health/healthyliving/Why-immunisation-is-important

www.healthlinkbc.ca/health-topics/hw255342

www.who.int/topics/immunization/en/

www.immunize.ca/what-immunization

www.who.int/news/item/17-05-2026-epidemic-of-ebola-disease-in-the-democratic-republic-of-the-congo-and-uganda-determined-a-public-health-emergency-of-international-concern